SARS-CoV-2 research significantly benefits from studying genetic mutations that alter viral infectivity, pathogenicity, and host immune response. These variations span single and multi-nucleotide polymorphisms, structural changes, and chromosomal aberrations like copy number variations and insertions/deletions. Pinpointing crucial genetic variations that influence host susceptibility and infection severity is vital for comprehending disease progression, developing treatments, and guiding public health strategies.